11,12-epoxyeicosatrienoic acid (11,12-EET): structural determinants for inhibition of TNF-alpha-induced VCAM-1 expression.

[1]  R. Mazucco,et al.  American Chemical Society--225th national meeting. 23-27 March 2003, New Orleans, LA, USA. , 2003, IDrugs : the investigational drugs journal.

[2]  S. Archer,et al.  Endothelium-Derived Hyperpolarizing Factor in Human Internal Mammary Artery Is 11,12-Epoxyeicosatrienoic Acid and Causes Relaxation by Activating Smooth Muscle BKCa Channels , 2003, Circulation.

[3]  J. Falck,et al.  Biochemical and molecular properties of the cytochrome P450 arachidonic acid monooxygenases. , 2002, Prostaglandins & other lipid mediators.

[4]  R. Busse,et al.  Dynamic Modulation of Interendothelial Gap Junctional Communication by 11,12-Epoxyeicosatrienoic Acid , 2002, Circulation research.

[5]  H. Hopf,et al.  Synthesis of cyclo-1,3-dien-5-ynes. , 2001, Chemistry.

[6]  D. Thompson,et al.  Pathways of Epoxyeicosatrienoic Acid Metabolism in Endothelial Cells , 2001, The Journal of Biological Chemistry.

[7]  A. A. Spector,et al.  Binding of cytochrome P450 monooxygenase and lipoxygenase pathway products by heart fatty acid-binding protein. , 2001, Biochemistry.

[8]  R. Roman,et al.  Renal And Cardiovascular Actions Of 20‐Hydroxyeicosatetraenoic Acid And Epoxyeicosatrienoic Acids , 2000, Clinical and experimental pharmacology & physiology.

[9]  W. Campbell,et al.  11,12-Epoxyeicosatrienoic acid stimulates endogenous mono-ADP-ribosylation in bovine coronary arterial smooth muscle. , 1999, Circulation research.

[10]  K. Ley,et al.  Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. , 1999, Science.

[11]  M. Kashio,et al.  Iridium Complex-Catalyzed Allylic Alkylation of Allylic Esters and Allylic Alcohols: Unique Regio- and Stereoselectivity , 1998 .

[12]  H. Kotsuki,et al.  Efficient method for the reductive cleavage of acetals and ketals with Zn(BH4)2/Me3SiCl , 1987 .

[13]  P. Laduron.  Criteria for receptor sites in binding studies. , 1984, Biochemical pharmacology.

[14]  D. Zeldin,et al.  Metabolism of epoxyeicosatrienoic acids by cytosolic epoxide hydrolase: substrate structural determinants of asymmetric catalysis. , 1995, Archives of biochemistry and biophysics.

[15]  J. Drummond,et al.  Convenient procedure for the preparation of alkyl and aryl substituted N-(aminoalkylacyl)sulfonamides , 1988 .